4.6 Article

Frequency of LATE neuropathologic change across the spectrum of Alzheimer's disease neuropathology: combined data from 13 community-based or population-based autopsy cohorts

期刊

ACTA NEUROPATHOLOGICA
卷 144, 期 1, 页码 27-44

出版社

SPRINGER
DOI: 10.1007/s00401-022-02444-1

关键词

ADRD; Tau; NFT; Nondemented; Oldest-old; Epidemiology; APOE; ROS-MAP; Vantaa 85+; HAAS; CFAS; CC75C; The 90+study; ACT; VITA; Nun study; Biobank for aging studies; Mayo clinic study of aging

资金

  1. Academy of Finland [341007]
  2. Liv och Halsa Foundation
  3. Rossy Foundation
  4. Edmond Safra Philanthropic Foundation
  5. Sao Paulo Research Foundation [FAPESP 06/55318-1, 09/09134-4, 16/24326-0]
  6. Nancy and Buster Alvord Endowment
  7. Alzheimer's Research UK (ARUK) [ARUK-PhD2017-34, ARUK-PhD2014-19]
  8. UK Medical Research Council (MRC) [MRC/G9901400, U.1052.00.0013, G0900582]
  9. NHMRC Dementia Research Leadership Fellowship [NT113567]
  10. Addenbrooke's Charitable Trust [900108]
  11. Paul G. Allen Foundation
  12. ARUK NSG
  13. Alzheimer's Society [AS-PG-2019b-024]
  14. State funding for university-level health research [TYH2020231, TYH2022316]
  15. Addenbrooke's Charitable Trust
  16. National Institute for Health Research, Cambridge Biomedical Research Centre
  17. National Institute on Aging (NIA) [U24AG021886]
  18. National Institutes of Health [P30 AG072958, P30 AG072977, K08 AG065463, RF1 AG072080, K08 AG 065426, R01 AG038651, UF1 AG057707, R01AG021055, P30 AG066519, R01 AG061111]
  19. The National Institutes of Health [R01 AG057187, P30 AG072946, RF1 NS118584, R01 AG054449, RF1 AG069052, P30 AG072972, R01 AG062517, U19 AG069701, K24 AG053435, R01AG067482, R01AG064233, R01AG022018, P30AG010161/P30AG072975, P30 AG062677, UF1 NS125417, U01 AG006786, R01 AG034676, P30 AG66509, U19 AG066567]
  20. Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [16/24326-0] Funding Source: FAPESP

向作者/读者索取更多资源

Limbic-predominant age-related TDP-43 encephalopathy neuropathologic change (LATE-NC) and Alzheimer's disease neuropathologic change (ADNC) are both associated with cognitive impairment in aging populations, with LATE-NC being present in approximately 40% of participants and more commonly in cases with poorer cognitive abilities.
Limbic-predominant age-related TDP-43 encephalopathy neuropathologic change (LATE-NC) and Alzheimer's disease neuropathologic change (ADNC) are each associated with substantial cognitive impairment in aging populations. However, the prevalence of LATE-NC across the full range of ADNC remains uncertain. To address this knowledge gap, neuropathologic, genetic, and clinical data were compiled from 13 high-quality community- and population-based longitudinal studies. Participants were recruited from United States (8 cohorts, including one focusing on Japanese-American men), United Kingdom (2 cohorts), Brazil, Austria, and Finland. The total number of participants included was 6196, and the average age of death was 88.1 years. Not all data were available on each individual and there were differences between the cohorts in study designs and the amount of missing data. Among those with known cognitive status before death (n = 5665), 43.0% were cognitively normal, 14.9% had MCI, and 42.4% had dementia-broadly consistent with epidemiologic data in this age group. Approximately 99% of participants (n = 6125) had available CERAD neuritic amyloid plaque score data. In this subsample, 39.4% had autopsy-confirmed LATE-NC of any stage. Among brains with frequent neuritic amyloid plaques, 54.9% had comorbid LATE-NC, whereas in brains with no detected neuritic amyloid plaques, 27.0% had LATE-NC. Data on LATE-NC stages were available for 3803 participants, of which 25% had LATE-NC stage > 1 (associated with cognitive impairment). In the subset of individuals with Thal A beta phase = 0 (lacking detectable A beta plaques), the brains with LATE-NC had relatively more severe primary age-related tauopathy (PART). A total of 3267 participants had available clinical data relevant to frontotemporal dementia (FTD), and none were given the clinical diagnosis of definite FTD nor the pathological diagnosis of frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP). In the 10 cohorts with detailed neurocognitive assessments proximal to death, cognition tended to be worse with LATE-NC across the full spectrum of ADNC severity. This study provided a credible estimate of the current prevalence of LATE-NC in advanced age. LATE-NC was seen in almost 40% of participants and often, but not always, coexisted with Alzheimer's disease neuropathology.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据